BMG Pharma enters into a long-term partnership Luqa Pharmaceuticals to distribute medical products in Hong Kong and China.
Deals
Financial Institutions may shy away from funding Delhi-Jaipur expressway if land not acquired
India’s Road Minister Oscar Fernandes said that unless major lands are handed over, financial institutions that would lend for the construction of expressways in the country could possibly shy away.
CCI takes call after getting more information on Jet-Etihad deal
The Competition Commission of India (CCI) said that it would approve the proposed Jet-Etihad deal provided that the two carriers supply it with enough information.
Riverside acquires enough shares to control Simcro Ltd
Simcro sells Riverside Co enough shares for the American company to control it. The Riverside Co. , a U. S. private equity firm, has made its primary entry into New Zealand, taking up a large percentage of the stake in Simcro Ltd.
French company offers Invensys GBP3.3 billion
Invensys recieved a buyout offer of GBP3.3 billion from a French firm. Invensys yesterday declared it has received a GBP3. 3 billion buyout bid from Schneider Electric, a French conglomerate.
Latest News
A New Zealand company submitted its offer to join a New Zealand-Taiwan venture capital fund. New Zealand firm has sent an application to join a Taiwan and New Zealand joint investment fund.
China and US agreed last Thursday to reinstate a stalled negotiations over an investment treaty. China and the United States of America agreed on Thursday to restart the halted investment negotiation treaty.
Direct Energy announced that they have reached an agreement to acquire Bounce Energy for US$46 million
MPTC to acquire 60% stake claim for Medicago for US$357 million Medicago Inc announced that it has entered into a definitive agreement with Mitsubishi Tanabe Pharma Corporation (MPTC).
Oak Tree Group, which aims to build more retirement homes for senior citizens, gets US $18.3 million investment from Blue Sky Private Equity.
Grohe received expression of interests from two potential buyers that would take part in the company's proposed sale.
ViaCyte raised US$10 million from private equity investments. A developer of diabetes treatment methods from human embryonic stem cells,ViaCyte, has more than US$10 million in a private equity funding.
Swiss Re announced that they are in preliminary talks with Phoenix Group Holdings for possible merger
US fixed income mutual funds attracted deposits from investors that came from redemption rebounds after the Federal Reserve announced scaling back of its stimulus.
